Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04071392 · ClinicalTrials.gov registry record

Development of an Intrauterine Pressure Threshold to Confirm Tubal Occlusion

A clinical trial, sponsored by Oregon Health and Science University.

Completed
Registry status
24
Enrollment target

NCT04071392 is a clinical trial that has completed, run by Oregon Health and Science University. The registered enrollment target is 24 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04071392 has completed, sponsored by Oregon Health and Science University.

COMPLETED
Registry status
24 participants
Enrollment target

Study Summary

The overarching goal of this study is to find an alternative method to hysterosalpingogram (HSG) to confirm bilateral tubal occlusion after permanent contraception.

Interventions

  • PROCEDURE Hysterosalpingogram (HSG)

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2016-09-01
Est. Completion 2017-07-31

What the Registry Record Tells You About NCT04071392

The ClinicalTrials.gov registry entry for NCT04071392 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Hysterosalpingogram (HSG) is the first listed.

NCT04071392 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04071392 about?

NCT04071392 is a clinical study titled "Development of an Intrauterine Pressure Threshold to Confirm Tubal Occlusion". The overarching goal of this study is to find an alternative method to hysterosalpingogram (HSG) to confirm bilateral tubal occlusion after permanent contraception.

What is the current status of trial NCT04071392?

This trial is currently completed. The enrollment target is 24 participants. The study started on 2016-09-01. Estimated completion is 2017-07-31.

What interventions are being tested in trial NCT04071392?

The interventions under investigation include: Hysterosalpingogram (HSG) (PROCEDURE).

Who is sponsoring clinical trial NCT04071392?

This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.